MDMA's 19th Annual Coverage, Reimbursement
& Health Policy Conference
*Speakers will be added as confirmed
Click Here for a PDF of the Agenda
Wednesday, November 16, 2016
1:30pm - 5:00pm - An Introduction to Reimbursement
Questions about whether or how medical devices will be reimbursed, what it will take to establish reimbursement, and how long the process will take are prominent in conversations between medical device manufacturers and their multiple stakeholders. Manufacturers need to understand how reimbursement influences access, and how payers and providers evaluate clinical evidence, pricing, and payment before adopting technology. This session will introduce the foundation of medical device reimbursement (coverage, codes, and payment) as these processes intersect in the current and evolving healthcare environment, and will focus on creating an implementable strategy so a product can be commercialized. At the end of the session, we will facilitate an idea exchange with participants to discuss product-specific reimbursement questions and issues to begin to put this information into practice.
5:00pm - 6:30pm - Networking Reception
Thursday, November 17, 2016
7:30am - 8:55am - Networking & Continental Breakfast
8:55am - 9:00am - Welcoming Remarks
9:00am - 9:45am -CMS Update
Earlier this year, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule implementing provisions from the Medicare Access and CHIP Reauthorization Act (MACRA) that change the way Medicare pays physicians, moving to value-based and alternative payment models. The agency is also engaged in complementary efforts with several pilots that tie reimbursement to the value of health care provided to Medicare beneficiaries. As CMS continues to develop new reimbursement models and incentives for innovators, hear from the agency on how you and your teams can prepare for this new environment, and what other reforms CMS is working on.
9:45am - 10:30am -Pay-for-Value
Over the last few years, the healthcare reimbursement landscape has begun to shift towards a greater emphasis on quality and value after decades of fee-for-service payments. Both Medicare and commercial payers are piloting and/or implementing efforts to reduce costs and improve care coordination and quality of healthcare delivery. Learn about the current and changing reimbursement landscape, including changes in evidentiary requirements in quality and performance measurement, what it could mean for you, and if there is a future for fee-for-service in the shifting landscape.
10:30am - 10:45am - Networking Break
10:45am - 11:30am - Evidence
The design of your clinical trial is often the "make or break" decision that impacts your ability to obtain coverage and reimbursement. The shifting reimbursement landscape towards quality and value also requires a shift in the way we think about clinical trial design. Learn the differences between and challenges of superiority versus non-inferiority trials and the need for these trials in a quality focused health insurance environment. Hear from experts on how to engage commercial payers on device trials and the role you have as a manufacturer in patient-determined outcomes at the FDA.
11:30am - 12:15pm - Medicare Coverage
We expect Medicare fee-for-service coverage policy and its evidence reviews will continue to be a benchmark even as Medicare moves to alternative value based payment systems. Hear from a leading CMS policy maker what the agency is doing to support the development of evidence for new devices. Learn strategies for meeting with local Medicare Administrative Contractors (MACs), how to demonstrate value of the device, and what mistakes to avoid while working with local MACs.
12:15pm - 1:15pm - Buffet Luncheon & Election Update
MDMA’s President & CEO will provide an update on Congressional and election activities, and what to expect with a new administration and Congress in place for 2017 and beyond.
1:15pm - 2:00pm - Navigating CPT and RUC
The CPT and RUC processes can be confusing and challenging. A former AMA CPT Director will help you understand what evidence you need to secure a CPT code and maximize your product's reimbursement, while a current AMA staff member will provide a background of the RUC and how the RUC provides value recommendations to CMS.
2:00pm - 3:00pm - Demonstrating Value to Private Payers and Providers
In today’s environment medical technology companies must demonstrate the value and patient benefit of their product to providers and payers. Leading experts will share what payers and providers are looking for today from medical technologies and will review steps companies can take to help ensure their technologies get into the hands of patients and providers.
3:00pm - 3:15pm - Networking Break
3:15pm - 4:15pm - International Session
International Reimbursement issues continue to change and present problems for medical device manufacturers. Learn about the status of China's procedure code and procurement policies, new changes in the German innovation payment, and the UK's web based formularies for devices and more.
Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.